BiotechTube
ChromaTwist

ChromaTwist

Cambridge, United Kingdom· Est.
chromatwist.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

ChromaTwist is a private, early-stage biotech spin-out from the University of Birmingham, founded in 2021 and based in Cambridge (with R&D operations in Birmingham). The company has developed a patented platform for novel large Stokes shift fluorescent dyes, which enhance multiplexing capabilities in critical life science tools like flow cytometers and microscopes. It has transitioned to early revenue through a supply agreement with Merck (Sigma-Aldrich) and the sale of chemical precursors, supported by grants and angel investment. ChromaTwist aims to expand its product portfolio and applications within the healthcare and diagnostics sectors.

Genetics & GenomicsSynthetic Biology

Technology Platform

Patented platform for designing and synthesizing large Stokes shift organic fluorescent dyes. The technology is based on novel molecular structures (e.g., phenoxazoles) that allow excitation by UV/blue light and emit bright, tunable light across the visible spectrum. The chemistry is modular and scalable.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The growing demand for high-parameter flow cytometry and advanced microscopy creates a direct need for novel fluorescent dyes with superior properties like a large Stokes shift.
Expansion into conjugated antibodies and kits represents a significantly larger addressable market within the research reagents space.
The core technology also has potential applications beyond life sciences, in areas such as materials science, solar cells, and OLEDs.

Risk Factors

Intense competition from established life science reagent giants with vast portfolios and sales reach poses a significant market penetration challenge.
The company's financial stability is reliant on continued angel investment and early commercial sales, creating runway risk.
Technological risks include scaling up synthesis and demonstrating consistent performance advantages over existing dyes in complex biological applications.

Competitive Landscape

ChromaTwist competes in the fluorescent dye and probe market against dominant players like Thermo Fisher Scientific, BD Biosciences, BioLegend, and Sony Biotechnology. Its differentiation is its specialized, patented large Stokes shift technology, which is less common than conventional small Stokes shift dyes. Other competitors include specialty dye companies like Lumiprobe and ATTO-TEC, as well as academic spin-outs with novel dye technologies. ChromaTwist's partnership with Merck is a key strategic asset for distribution.

More companies in United Kingdom →